Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
10 results for “Ademi LLP”
Shareholder Alert: Ademi LLP investigates whether Bowhead Specialty Holdings Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether Bowhead Specialty Holdings Inc. received fair value for its shareholders in a transaction with American Family, raising questions about fiduciary duty and legal compliance.
Aug 3, 2026
Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether Supernus Pharmaceuticals' proposed transaction with Indivior Pharmaceuticals violates fiduciary duties or other laws, raising questions about fairness to public shareholders.
Aug 3, 2026
Shareholder Alert: Ademi LLP investigates whether MarketAxess Holdings Inc. is obtaining a Fair Price for Public Shareholders
A law firm has launched a shareholder investigation into MarketAxess’s proposed acquisition by Intercontinental Exchange, questioning whether public shareholders are receiving fair value.
Jul 30, 2026
Shareholder Alert: Ademi LLP investigates whether Safety Insurance Group, Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether Safety Insurance Group's proposed acquisition by Mapfre delivers fair value to public shareholders, raising concerns about fiduciary duty compliance.
Jul 24, 2026
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether BioLife Solutions' proposed acquisition by Repligen offers fair value to public shareholders, raising questions about fiduciary obligations and transaction legality.
Jul 22, 2026
Shareholder Alert: Ademi LLP investigates whether AtaiBeckley Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether AtaiBeckley Inc. violated fiduciary duties in its transaction with Eli Lilly, raising questions about fairness to public shareholders.
Jul 16, 2026
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GPGI, Inc.
A law firm is investigating potential securities fraud allegations against GPGI, Inc. related to allegedly inaccurate disclosures about its financials, operations, and future prospects — raising material investor risk.
Jul 16, 2026
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against IBM
A law firm has launched a securities fraud investigation into IBM over alleged inaccurate statements about its financials, operations, and future prospects.
Jul 15, 2026
Shareholder Alert: Ademi LLP investigates whether TriCo Bancshares is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether TriCo Bancshares provided fair value to public shareholders in its acquisition by First Hawaiian, raising questions about fiduciary duty compliance.
Jul 13, 2026
Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
A law firm is investigating whether Crinetics Pharmaceuticals’ proposed transaction with Vertex constitutes a breach of fiduciary duty and fails to deliver fair value to public shareholders.
Jul 8, 2026